Myomo Inc (STU:0M61)
€ 4.545 0.08 (1.79%) Market Cap: 138.33 Mil Enterprise Value: 132.36 Mil PE Ratio: 0 PB Ratio: 15.96 GF Score: 55/100

Q3 2024 Myomo Inc Earnings Call Transcript

Nov 06, 2024 / 09:30PM GMT
Release Date Price: €3.89 (+8.52%)

Key Points

Positve
  • Myomo Inc (MYO) achieved a record revenue of $9.2 million in Q3 2024, marking an 83% increase over the same period in 2023.
  • The company successfully added 645 medically qualified candidates to its patient pipeline, a 69% increase from the previous year.
  • Myomo Inc (MYO) has entered into its first two contracts with Blue Cross Blue Shield of Massachusetts and Paradigm, representing 3 million covered lives.
  • The company has expanded its manufacturing capacity and plans to move to a larger facility to accommodate expected growth.
  • International operations, particularly in Germany, continue to perform well with a record $1.1 million in revenue for the quarter.
Negative
  • Myomo Inc (MYO) faces challenges with some Medicare Advantage plans, which are making it difficult for patients and providers to get necessary care, leading to more initial denials and appeals.
  • Operating expenses increased by 43% compared to the third quarter of 2023, driven by higher headcount and advertising costs.
  • The company reported a net loss of $1 million for Q3 2024, although this was an improvement from the previous year.
  • There is a potential for gross margin compression as the O&P channel grows, due to lower ASPs in this channel.
  • The process of establishing contracts with payers for in-network status is expected to be a multi-year endeavor, potentially delaying revenue growth from this initiative.
Operator

Good day and welcome to the Myomo third quarter, 2024 financial results conference call. (Operator Instructions)

Please note this event is being recorded.

I would now like to turn the conference over to Kim Golodetz. Please go ahead.

Kim Golodetz
LHA Investor Relations - Investor Relations

Thank you operator and good afternoon everyone. This is Kim Golodetz with alliance advisors. Ir Welcome to the Myomo third quarter 2024 conference call.

Earlier this afternoon, Myomo issued a news release announcing financial results for the three and nine months ended. September 30th 2024. If you would like to be added to the company's email distribution list to receive future announcements, please register on the company's website at Myomo dotcom or call alliance advisors. Ir at 3,106,917,100 and speak with Danny Chertok with me on today's call from Myomo are Paul Gudonis, Chairman and Chief Executive Officer and Dave Henry, Chief Financial Officer. Before we begin, I'd like to caution listeners that statements made during this conference call

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot